Alice Tzeng
Alice Tzeng
Brigham and Women's Hospital
Verified email at
Cited by
Cited by
Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
KD Moynihan, CF Opel, GL Szeto, A Tzeng, EF Zhu, JM Engreitz, ...
Nature medicine 22 (12), 1402-1410, 2016
Antigen specificity can be irrelevant to immunocytokine efficacy and biodistribution
A Tzeng, BH Kwan, CF Opel, T Navaratna, KD Wittrup
Proceedings of the National Academy of Sciences 112 (11), 3320-3325, 2015
Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer
A Tzeng, N Sangwan, M Jia, CC Liu, KS Keslar, E Downs-Kelly, ...
Genome Medicine 13, 1-17, 2021
The intestinal flora is required to support antibody responses to systemic immunization in infant and germ free mice
ES Lamousť-Smith, A Tzeng, MN Starnbach
PloS one 6 (11), e27662, 2011
Protein engineering and selection using yeast surface display
A Angelini, TF Chen, S de Picciotto, NJ Yang, A Tzeng, MS Santos, ...
Yeast Surface Display: Methods, Protocols, and Applications, 3-36, 2015
Treating periprosthetic joint infections as biofilms: key diagnosis and management strategies
A Tzeng, TH Tzeng, S Vasdev, K Korth, T Healey, J Parvizi, KJ Saleh
Diagnostic microbiology and infectious disease 81 (3), 192-200, 2015
Temporally programmed CD8α+ DC activation enhances combination cancer immunotherapy
A Tzeng, MJ Kauke, EF Zhu, KD Moynihan, CF Opel, NJ Yang, N Mehta, ...
Cell reports 17 (10), 2503-2511, 2016
Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses
BH Kwan, EF Zhu, A Tzeng, HR Sugito, AA Eltahir, B Ma, MK Delaney, ...
Journal of Experimental Medicine 214 (6), 1679-1690, 2017
Evaluation and management of metal hypersensitivity in total joint arthroplasty: a systematic review
M Amini, WH Mayes, A Tzeng, TH Tzeng, KJ Saleh, WM Mihalko
Journal of long-term effects of medical implants 24 (1), 2014
Immunological correlates of response to immune checkpoint inhibitors in metastatic urothelial carcinoma
A Tzeng, CM Diaz-Montero, PA Rayman, JS Kim, PG Pavicic, JH Finke, ...
Targeted Oncology 13, 599-609, 2018
The role of patient activation in achieving better outcomes and cost-effectiveness in patient care
A Tzeng, TH Tzeng, S Vasdev, A Grindy, JK Saleh, KJ Saleh
JBJS reviews 3 (1), e4, 2015
Order of administration of combination cytokine therapies can decouple toxicity from efficacy in syngeneic mouse tumor models
A Rothschilds, A Tzeng, NK Mehta, KD Moynihan, DJ Irvine, KD Wittrup
Oncoimmunology 8 (5), e1558678, 2019
Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis
A Tzeng, TH Tzeng, MC Ornstein
Journal for Immunotherapy of Cancer 9 (10), 2021
Interplay between class II HLA genotypes and the microbiome and immune phenotypes in individuals with PTEN hamartoma tumor syndrome
M Jia, N Sangwan, A Tzeng, C Eng
JCO precision oncology 5, 357-369, 2021
Safety and Efficacy Outcomes in Immune Checkpoint Inhibitor-Treated Patients With Metastatic Urothelial Carcinoma Requiring Treatment Interruption or Discontinuation Due to†…
A Nizam, RK Rader, A Tzeng, W Wei, IYF Sheng, A Martin, CE Wee, ...
Clinical Genitourinary Cancer 22 (2), 368-379, 2024
Fecal microbiota of adolescent and young adult cancer survivors and metabolic syndrome: An exploratory study
SJ Rotz, N Sangwan, M Nagy, A Tzeng, M Jia, M Moncaliano, NS Majhail, ...
Pediatric hematology and oncology 39 (7), 629-643, 2022
Serial changes in PD1/PDL1 expression in metastatic urothelial carcinoma (mUC) patients (pts) treated with immune checkpoint blockade (CPB).
A Tzeng, CM Diaz-Montero, PA Rayman, JS Kim, PG Pavicic, J Finke, ...
Journal of Clinical Oncology 36 (5_suppl), 109-109, 2018
Multi-specific antibodies with affinity for human A33 antigen and DOTA metal complex and uses thereof
SM Cheal, H Xu, SM Larson, NK Cheung, KD Wittrup
Bispecific antibodies specific for treating hematological malignancies
DJ Green, Y Lin, OW Press, A Tzeng, KD Wittrup
US Patent 11,970,542, 2024
Pneumonitis in Patients Receiving Thoracic Radiotherapy and Osimertinib: A Multi-Institutional Study
LI Banla, A Tzeng, JP Baillieul, MJ Kandekhar, KJ Fitzgerald, J LoPiccolo, ...
JTO Clinical and Research Reports 4 (10), 100559, 2023
The system can't perform the operation now. Try again later.
Articles 1–20